We are live on
!
Find out more
AE
AMH Equity Portfolio holdings
AUM
$80.3M
1-Year Est. Return
78.34%
This Fund
S&P 500
This Quarter
Est. Return
-8.72%
1 Year Est. Return
+78.34%
3 Year Est. Return
+267.47%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$75.4M
AUM Growth
-$26.5M
(-26%)
Cap. Flow
-$16.8M
Cap. Flow
% of AUM
-22.31%
Top 10 Holdings %
Top 10 Hldgs %
68.18%
Holding
45
New
5
Increased
11
Reduced
13
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Algoma Steel
ASTL
|
+$3.09M |
| 2 |
BNBX
BNB PLUS CORP
BNBX
|
+$2.13M |
| 3 |
Universal Electronics
UEIC
|
+$2.08M |
| 4 |
Biodesix
BDSX
|
+$994K |
| 5 |
INFN
Infinera Corporation Common Stock
INFN
|
+$899K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Orion Group Holdings
ORN
|
+$8.46M |
| 2 |
Conduent
CNDT
|
+$4.83M |
| 3 |
Myriad Genetics
MYGN
|
+$2.35M |
| 4 |
Smith & Wesson
SWBI
|
+$1.74M |
| 5 |
Arrow Electronics
ARW
|
+$1.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.14% |
| 2 | Industrials | 24.25% |
| 3 | Healthcare | 15.05% |
| 4 | Materials | 3.69% |
| 5 | Consumer Discretionary | 2.77% |
Similar funds
BHMP
BCCM
MM
ASM
BPC
KDIA
LMKC
CM
AMH Equity's Q2 2024 Portfolio in Review
As of Q2 2024, AMH Equity held 45 positions worth $75.4M, down 26% from $102M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
AMH Equity withdrew a net $16.8M in Q2 2024, closing 11 positions and reducing 13 holdings. Its most notable exit was Myriad Genetics, an estimated $2.35M position sold in full.
By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 35% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, AMH Equity opened a new position in Algoma Steel worth $2.78M.
- AMH Equity's largest Q2 2024 buy was Algoma Steel: 400,000 shares worth $2.78M.
- AMH Equity added most to BNB PLUS CORP in Q2 2024, an estimated $2.13M increase.
- AMH Equity's biggest Q2 2024 reduction was Orion Group Holdings, cutting an estimated $8.46M.
- AMH Equity fully exited Myriad Genetics in Q2 2024, selling an estimated $2.35M.
- AMH Equity's ten largest holdings make up 68% of its $75.4M portfolio in Q2 2024.
- AMH Equity opened 5 new positions and closed 11 in Q2 2024.
- AMH Equity's portfolio value fell 26% quarter-over-quarter to $75.4M.
Based on AMH Equity's 13F filing for Q2 2024, filed 6 Aug 2024.